Vishal Kamat
Intarcia Therapeutics (United States)
ORCID: 0000-0002-6299-7024MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response”.
58 citations
Matthew C. Franklin, Vishal Kamat, Annabel Romero Hernandez, Ashok Badithe, Li‐Hong Ben +8 more
64 citations
Lily Huang, Lili Wang, Nanditha Das, Sandra Reisman, Yonaton Ray +16 more